Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May;81(5):991-1007.
doi: 10.1161/HYPERTENSIONAHA.123.21356. Epub 2024 Mar 1.

Hypertension, Neurodegeneration, and Cognitive Decline

Anthony Pacholko  1 , Costantino Iadecola  1
Affiliations
Review

Hypertension, Neurodegeneration, and Cognitive Decline

Anthony Pacholko et al. Hypertension. 2024 May.

Abstract

Elevated blood pressure is a well-established risk factor for age-related cognitive decline. Long linked to cognitive impairment on vascular bases, increasing evidence suggests a potential association of hypertension with the neurodegenerative pathology underlying Alzheimer disease. Hypertension is well known to disrupt the structural and functional integrity of the cerebral vasculature. However, the mechanisms by which these alterations lead to brain damage, enhance Alzheimer pathology, and promote cognitive impairment remain to be established. Furthermore, critical questions concerning whether lowering blood pressure by antihypertensive medications prevents cognitive impairment have not been answered. Recent developments in neurovascular biology, brain imaging, and epidemiology, as well as new clinical trials, have provided insights into these critical issues. In particular, clinical and basic findings on the link between neurovascular dysfunction and the pathobiology of neurodegeneration have shed new light on the overlap between vascular and Alzheimer pathology. In this review, we will examine the progress made in the relationship between hypertension and cognitive impairment and, after a critical evaluation of the evidence, attempt to identify remaining knowledge gaps and future research directions that may advance our understanding of one of the leading health challenges of our time.

Keywords: Alzheimer disease; blood pressure; brain; hypertension; stroke.

PubMed Disclaimer

Conflict of interest statement

Disclosures C. Iadecola serves on the scientific advisory board of Broadview Ventures. The other author reports no conflicts.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Swan GE, DeCarli C, Miller BL, et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology. 1998;51(4):986–983. - PubMed
    1. Gottesman RF, Schneider AL, Albert M, et al. Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. JAMA neurology. 2014;71(10):1218–1227. - PMC - PubMed
    1. Gottesman RF, Albert MS, Alonso A, et al. Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort. JAMA neurology. 2017;74(10):1246–1254. - PMC - PubMed
    1. Kety SS, Hafkenschiel JH. The blood flow, vascular resistance, and oxygen consumption of the brain in essential hypertension. The Journal of clinical investigation. 1948;27(4):511–514 - PubMed
    1. Leopold IH, Kety SS. Correlation of the cerebrovascular resistance and the grade of hypertensive retinal findings. American journal of ophthalmology. 1949;32(3):365–368. - PubMed

Substances